Which country is Sotoraxibu produced in?

Sotoracib is an anti-cancer drug developed by the American biotechnology companyAmgen . Amgen is a global biotechnology company headquartered in California, focusing on research and development in the field of biomedicine. The company is committed to innovative treatments, including targeted therapies, biologics and genetically engineered drugs. Amgen is the company that develops and manufactures sotoracib. This means that Sotolaxib is produced by an American company. Please note that the manufacturing and marketing of medicines may change over time, and it is recommended that you check the latest drug information or consult a medical professional for the most accurate information.